AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Keynotes Highlight Basic and Clinical Research
Cancers are driven by unique genetic alterations, so what if we targeted these alterations to treat the cancer? It seems...
Tag: AACR
Cancers are driven by unique genetic alterations, so what if we targeted these alterations to treat the cancer? It seems...
In the opening keynote session of the AACR Special Conference on Pancreatic Cancer, which took place September 27-30 in...
In 2021, Lillian L. Siu, MD, and Elaine R. Mardis, PhD, FAACR, each received a call from AACR Chief...
As the temperatures start to drop and the leaves begin to change color, enjoy the latest selection of studies...
On December 23, 1971, when President Richard Nixon signed the National Cancer Act of 1971 into law, cancer was considered a death sentence. Only 42 percent of those diagnosed with cancer survived five years past diagnosis,...
The effects of the coronavirus pandemic have rippled through the entire cancer community, from individual patients to the world’s...
The American Association for Cancer Research (AACR) and its Minorities in Cancer Research (MICR) membership group today issued a...
Since 2011, immunotherapy has emerged as an exciting new approach to cancer treatment that is yielding unprecedented, durable responses...
Building on advances in technology and analytical tools, real-world data (RWD) sources have attracted increasing interest as means to...
The Fifth AACR New Horizons in Cancer Research (NHiCR) international conference has concluded, and the more than 400 attendees...